EDGAR Filing Documents for 0001104659-17-020396

Form 8-K - Current report:

SEC Accession No. 0001104659-17-020396

Filing Date

2017-03-30

Accepted

2017-03-30 16:45:43

Documents

Period of Report

2017-03-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-9987_18k.htm	8-K	30386
2	EX-1.1	a17-9987_1ex1d1.htm	EX-1.1	231896
3	EX-5.1	a17-9987_1ex5d1.htm	EX-5.1	10876
4	EX-99.1	a17-9987_1ex99d1.htm	EX-99.1	12476
5	EX-99.2	a17-9987_1ex99d2.htm	EX-99.2	11327
6	GRAPHIC	g99871kii001.jpg	GRAPHIC	2585
7	GRAPHIC	g99871moi001.jpg	GRAPHIC	4186
8	GRAPHIC	g99871mmi001.jpg	GRAPHIC	4186
	Complete submission text file	0001104659-17-020396.txt		313631

Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139

Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580

Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)